A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers
Clinical trial NCT05215912 · COMPLETED
Trial details
- NCT number
- NCT05215912
- Sponsor
- TeneoFour Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2023-05-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.